AOD Use Trajectories from Age 10 to 24: Multi-level Predictors, Health, and Behavioral Functioning, and Racial/ethnic Disparities

10 至 24 岁的 AOD 使用轨迹:多级预测因素、健康和行为功能以及种族/民族差异

基本信息

  • 批准号:
    10088639
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-20 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Summary/Abstract This administrative supplement responds to NOT-OD-20-032; Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations. Alcohol and other drug (AOD) use is a significant contributor to health and other functional disparities among sexual and gender minorities (SGMs). Some SGM individuals, particularly young adults, are more likely to use AOD compared to non-SGM peers. Prior work has reported on functional disparities across SGM and non-SGM young people, as well as differences in longitudinal patterns of AOD use across these groups. However, few studies have addressed how developmental trajectories of AOD use during adolescence and emerging adulthood may contribute to the emergence of disparities for SGM young adults, especially across multiple domains of functioning (e.g., academic and occupational functioning; social functioning). For example, very little is known regarding whether trajectories of AOD use during these important developmental periods may disproportionately affect outcomes for SGM individuals, or which domains of functioning may be differentially affected in young adulthood. Given that disparities may appear across a variety of different domains, it is crucial to assess AOD- related disparities across multiple domains of functioning to better understand how these negative outcomes may manifest for SGM individuals. Additionally, evidence suggests that subgroups of SGMs may differ with respect to patterns of AOD use, yet little research has addressed the emergence of AOD-related functional disparities within SGMs (e.g., by race/ethnicity). The proposed supplement research will utilize existing longitudinal data from the ongoing STudy of Racial diversity in AOD use during the Transition to Adulthood (STRATA; R01AA025848) to address these gaps. The rich, demographically diverse STRATA dataset will allow us to assess different types of AOD use (alcohol, marijuana, and other drugs) and outcomes across multiple domains with a large longitudinal sample. Study aims are: Aim 1. Examine trajectories of AOD use (i.e., alcohol, marijuana, and other illicit drugs; examined in separate models) over 11 years from early adolescence through young adulthood as predictors of functioning across multiple domains within SGM young adults: 1) risk behaviors (e.g., sexual risk-taking, delinquency), 2) physical health, 3) mental health, 4) social /relationship functioning, 5) academic functioning, and 6) occupational functioning; Aim 2. Determine whether disparities exist by assessing whether trajectories of AOD use are differentially associated with functioning in young adulthood for SGM versus non-SGM peers; and Aim 3. Within SGMs, assess whether AOD use trajectories differentially predict outcomes across racial/ethnic groups (i.e., racial/ethnic disparities within SGM) and sex/gender. Study findings will provide critical information on the emergence of AOD-related disparities for SGMs and can inform prevention and intervention efforts to reduce AOD-related harms.
Summary/Abstract This administrative supplement responds to NOT-OD-20-032; Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations. Alcohol and other drug (AOD) use is a significant contributor to health and other functional disparities among sexual and gender minorities (SGMs). Some SGM individuals, particularly young adults, are more likely to use AOD compared to non-SGM peers. Prior work has reported on functional disparities across SGM and non-SGM young people, as well as differences in longitudinal patterns of AOD use across these groups. However, few studies have addressed how developmental trajectories of AOD use during adolescence and emerging adulthood may contribute to the emergence of disparities for SGM young adults, especially across multiple domains of functioning (e.g., academic and occupational functioning; social functioning). For example, very little is known regarding whether trajectories of AOD use during these important developmental periods may disproportionately affect outcomes for SGM individuals, or which domains of functioning may be differentially affected in young adulthood. Given that disparities may appear across a variety of different domains, it is crucial to assess AOD- related disparities across multiple domains of functioning to better understand how these negative outcomes may manifest for SGM individuals. Additionally, evidence suggests that subgroups of SGMs may differ with respect to patterns of AOD use, yet little research has addressed the emergence of AOD-related functional disparities within SGMs (e.g., by race/ethnicity). The proposed supplement research will utilize existing longitudinal data from the ongoing STudy of Racial diversity in AOD use during the Transition to Adulthood (STRATA; R01AA025848) to address these gaps. The rich, demographically diverse STRATA dataset will allow us to assess different types of AOD use (alcohol, marijuana, and other drugs) and outcomes across multiple domains with a large longitudinal sample. Study aims are: Aim 1. Examine trajectories of AOD use (i.e., alcohol, marijuana, and other illicit drugs; examined in separate models) over 11 years from early adolescence through young adulthood as predictors of functioning across multiple domains within SGM young adults: 1) risk behaviors (e.g., sexual risk-taking, delinquency), 2) physical health, 3) mental health, 4) social /relationship functioning, 5) academic functioning, and 6) occupational functioning; Aim 2. Determine whether disparities exist by assessing whether trajectories of AOD use are differentially associated with functioning in young adulthood for SGM versus non-SGM peers; and Aim 3. Within SGMs, assess whether AOD use trajectories differentially predict outcomes across racial/ethnic groups (i.e., racial/ethnic disparities within SGM) and sex/gender. Study findings will provide critical information on the emergence of AOD-related disparities for SGMs and can inform prevention and intervention efforts to reduce AOD-related harms.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH J. D'AMICO其他文献

ELIZABETH J. D'AMICO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH J. D'AMICO', 18)}}的其他基金

Life Course Perspective on Alcohol and Drug Use Trajectories from Adolescence into Adulthood
从青春期到成年的酒精和毒品使用轨迹的生命历程视角
  • 批准号:
    10616521
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Life Course Perspective on Alcohol and Drug Use Trajectories from Adolescence into Adulthood
从青春期到成年的酒精和毒品使用轨迹的生命历程视角
  • 批准号:
    10458782
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Life Course Perspective on Alcohol and Drug Use Trajectories from Adolescence into Adulthood
从青春期到成年的酒精和毒品使用轨迹的生命历程视角
  • 批准号:
    10293235
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10224983
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10252066
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10471953
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10204264
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    9892437
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10440189
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
为加利福尼亚州美洲印第安人/阿拉斯加原住民年轻人制定和实施以文化为中心的阿片类药物预防干预措施
  • 批准号:
    10689732
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
  • 批准号:
    10893074
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了